← Back to Search
Post-translational Modifications Of S1PR1 And Endothelial Barrier Regulation.
Mumtaz Anwar, D. Mehta
Published 2020 · Medicine
Save to my Library
Download via 🐼 PaperPanda Download via oaDOI Download via OAB Download via LibKey Download via Google Google ScholarAnalyze on Scholarcy Visualize in Litmaps
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Sphingosine-1-phosphate receptor-1 (S1PR1), a G-protein coupled receptor that is expressed in endothelium and activated upon ligation by the bioactive lipid sphingosine-1-phosphate (S1P), is an important vascular-barrier protective mechanism at the level of adherens junctions (AJ). Loss of endothelial barrier function is a central factor in the pathogenesis of various inflammatory conditions characterized by protein-rich lung edema formation, such as acute respiratory distress syndrome (ARDS). While several S1PR1 agonists are available, the challenge of arresting the progression of protein-rich edema formation remains to be met. In this review, we discuss the role of S1PRs, especially S1PR1, in regulating endothelial barrier function. We review recent findings showing that replenishment of the pool of cell-surface S1PR1 may be crucial to the effectiveness of S1P in repairing the endothelial barrier. In this context, we discuss the S1P generating machinery and mechanisms that regulate S1PR1 at the cell surface and their impact on endothelial barrier function.
This paper references
An abundant transcript induced in differentiating human endothelial cells encodes a polypeptide with structural similarities to G-protein-coupled receptors.
T. Hla (1990)
Plasmalemmal vesicles represent the large pore system of continuous microvascular endothelium.
D. Predescu (1993)
Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures.
B. V. Van Lenten (1995)
Sphingosine 1-phosphate, a bioactive sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum.
Y. Yatomi (1997)
Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1.
M. J. Lee (1998)
Sphingosine Kinase Expression Increases Intracellular Sphingosine-1-Phosphate and Promotes Cell Growth and Survival
A. Olivera (1999)
Association of β-Arrestin with G Protein-coupled Receptors during Clathrin-mediated Endocytosis Dictates the Profile of Receptor Resensitization*
R. Oakley (1999)
Differential Coupling of the Sphingosine 1-Phosphate Receptors Edg-1, Edg-3, and H218/Edg-5 to the Gi, Gq, and G12 Families of Heterotrimeric G Proteins*
R. Windh (1999)
Lipid phosphate phosphohydrolase-1 degrades exogenous glycerolipid and sphingolipid phosphate esters.
R. Jasinská (1999)
Differential Affinities of Visual Arrestin, βArrestin1, and βArrestin2 for G Protein-coupled Receptors Delineate Two Major Classes of Receptors*
R. Oakley (2000)
Endothelial Cell-Surface Gp60 Activates Vesicle Formation and Trafficking via Gi-Coupled Src Kinase Signaling Pathway
R. Minshall (2000)
Sequencing the entire genomes of free-living organisms: the foundation of pharmacology in the new millennium.
S. Broder (2000)
Molecular Cloning and Functional Characterization of a Novel Mammalian Sphingosine Kinase Type 2 Isoform*
Hong Liu (2000)
Interactions between nitric oxide and endothelin in the regulation of vascular tone of human resistance vessels in vivo.
C. Cardillo (2000)
Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation.
Y. Liu (2000)
Interaction of sphingosine 1-phosphate with plasma components, including lipoproteins, regulates the lipid receptor-mediated actions.
N. Murata (2000)
Molecular Determinants Underlying the Formation of Stable Intracellular G Protein-coupled Receptor-β-Arrestin Complexes after Receptor Endocytosis*
R. Oakley (2001)
Simvastatin Has Anti-Inflammatory and Antiatherosclerotic Activities Independent of Plasma Cholesterol Lowering
C. Sparrow (2001)
Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement.
J. Garcia (2001)
International Union of Pharmacology. XXXIV. Lysophospholipid Receptor Nomenclature
J. Chun (2002)
Characterization of Murine Sphingosine-1-phosphate Phosphohydrolase*
H. Le Stunff (2002)
Tandem genomic arrangement of a G protein (Gna15) and G protein‐coupled receptor (s1p4 /lpC1 /Edg6) gene
J. Contos (2002)
PKC-dependent Activation of Sphingosine Kinase 1 and Translocation to the Plasma Membrane
Korey R. Johnson (2002)
Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists
S. Mandala (2002)
Sphingosine-1-phosphate receptors and the development of the vascular system.
M. L. Allende (2002)
Activation‐regulated expression and chemotactic function of sphingosine 1‐phosphate receptors in mouse splenic T cells
M. Graeler (2002)
The immunosuppressant FTY720 is phosphorylated by sphingosine kinase type 2
S. Paugh (2003)
G-protein-coupled receptor S1P1 acts within endothelial cells to regulate vascular maturation.
M. L. Allende (2003)
Activation of sphingosine kinase 1 by ERK1/2‐mediated phosphorylation
S. Pitson (2003)
Structural and functional characteristics of S1P receptors
T. Sanchez (2004)
Physiological and pathological actions of sphingosine 1-phosphate.
T. Hla (2004)
Pulmonary Endothelial Cell Barrier Enhancement by Sphingosine 1-Phosphate
S. Dudek (2004)
Sphingosine-1-phosphate lyase SPL is an endoplasmic reticulum-resident, integral membrane protein with the pyridoxal 5'-phosphate binding domain exposed to the cytosol.
M. Ikeda (2004)
Endothelial cell barrier regulation by sphingosine 1‐phosphate
B. McVerry (2004)
Sphingosine 1-Phosphate (S1P) Receptor Subtypes S1P1 and S1P3, Respectively, Regulate Lymphocyte Recirculation and Heart Rate*
M. Sanna (2004)
Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1
M. Matloubian (2004)
Point-Counterpoint of Sphingosine 1-Phosphate Metabolism
J. Saba (2004)
SphK1 and SphK2, Sphingosine Kinase Isoenzymes with Opposing Functions in Sphingolipid Metabolism*
M. Maceyka (2005)
Essential Role for Sphingosine Kinases in Neural and Vascular Development
K. Mizugishi (2005)
c-Src is involved in regulating signal transmission from PDGFbeta receptor-GPCR(s) complexes in mammalian cells.
C. Waters (2005)
Phosphorylation-dependent translocation of sphingosine kinase to the plasma membrane drives its oncogenic signalling
S. Pitson (2005)
Kruppel-Like Factor 2 as a Novel Mediator of Statin Effects in Endothelial Cells
S. Sen-Banerjee (2005)
Sphingosine 1-Phosphate-induced Mobilization of Intracellular Ca2+ Mediates Rac Activation and Adherens Junction Assembly in Endothelial Cells*
D. Mehta (2005)
Type 4 sphingosine 1‐phosphate G protein‐coupled receptor (S1P4) transduces S1P effects on T cell proliferation and cytokine secretion without signaling migration
Wengang Wang (2005)
Edg8/S1P5: An Oligodendroglial Receptor with Dual Function on Process Retraction and Cell Survival
C. Jaillard (2005)
Sphingosine kinases, sphingosine 1-phosphate, apoptosis and diseases.
N. Hait (2006)
Antagonism of sphingosine-1-phosphate receptors by FTY720 inhibits angiogenesis and tumor vascularization.
K. Lamontagne (2006)
Kruppel-like factor 2 regulates thymocyte and T-cell migration
Corey M. Carlson (2006)
High-Density Lipoproteins and Their Constituent, Sphingosine-1-Phosphate, Directly Protect the Heart Against Ischemia/Reperfusion Injury In Vivo via the S1P3 Lysophospholipid Receptor
G. Theilmeier (2006)
Integration of flow-dependent endothelial phenotypes by Kruppel-like factor 2.
K. Parmar (2006)
Signaling mechanisms regulating endothelial permeability.
D. Mehta (2006)
The functional PDGFβ receptor–S1P1 receptor signaling complex is involved in regulating migration of mouse embryonic fibroblasts in response to platelet derived growth factor
J. Long (2006)
Extracellular export of sphingosine kinase-1a contributes to the vascular S1P gradient.
K. Venkataraman (2006)
Involvement of Rho Kinase in Endothelial Barrier Maintenance
G. P. van Nieuw Amerongen (2007)
Autocrine and paracrine roles of sphingosine-1-phosphate
Sergio E Alvarez (2007)
Induction of Vascular Permeability by the Sphingosine-1-Phosphate Receptor–2 (S1P2R) and its Downstream Effectors ROCK and PTEN
T. Sanchez (2007)
Vascular dysfunction in S1P2 sphingosine 1-phosphate receptor knockout mice.
J. Lorenz (2007)
Activation of sphingosine‐1‐phosphate receptor S1P5 inhibits oligodendrocyte progenitor migration
Alexander S. Novgorodov (2007)
Immunosuppressive and Anti-angiogenic Sphingosine 1-Phosphate Receptor-1 Agonists Induce Ubiquitinylation and Proteasomal Degradation of the Receptor*
M. Oo (2007)
Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor
T. Walzer (2007)
Endothelial cell barrier protection by simvastatin: GTPase regulation and NADPH oxidase inhibition.
Weiguo Chen (2008)
The alliance of sphingosine-1-phosphate and its receptors in immunity
J. Rivera (2008)
G‐protein‐coupled receptor phosphorylation: where, when and by whom
A. Tobin (2008)
The Spinster Homolog, Two of Hearts, Is Required for Sphingosine 1-Phosphate Signaling in Zebrafish
N. Osborne (2008)
Dendritic cell PAR1–S1P3 signalling couples coagulation and inflammation
F. Niessen (2008)
“Inside-Out” Signaling of Sphingosine-1-Phosphate: Therapeutic Targets
K. Takabe (2008)
Activation of Sphingosine Kinase-1 Reverses the Increase in Lung Vascular Permeability Through Sphingosine-1-Phosphate Receptor Signaling in Endothelial Cells
Mohammad Tauseef (2008)
VE-PTP maintains the endothelial barrier via plakoglobin and becomes dissociated from VE-cadherin by leukocytes and by VEGF
A. Nottebaum (2008)
Incomplete Inhibition of Sphingosine 1-Phosphate Lyase Modulates Immune System Function yet Prevents Early Lethality and Non-Lymphoid Lesions
P. Vogel (2009)
Regulation of Histone Acetylation in the Nucleus by Sphingosine-1-Phosphate
N. Hait (2009)
The structure and function of G-protein-coupled receptors
D. Rosenbaum (2009)
Akt-Mediated Transactivation of the S1P1 Receptor in Caveolin-Enriched Microdomains Regulates Endothelial Barrier Enhancement by Oxidized Phospholipids
P. Singleton (2009)
Targeted disruption of the S1P2 sphingosine 1-phosphate receptor gene leads to diffuse large B-cell lymphoma formation.
G. Cattoretti (2009)
Sphingosine 1-phosphate receptor signaling.
H. Rosen (2009)
Constitutive Internalization of G Protein-coupled Receptors and G Proteins via Clathrin-independent Endocytosis*
M. Scarselli (2009)
Subcellular Origin of Sphingosine 1-Phosphate Is Essential for Its Toxic Effect in Lyase-deficient Neurons*
N. Hagen (2009)
Molecular mechanisms of clathrin-independent endocytosis
C. G. Hansen (2009)
The Sphingolipid Transporter Spns2 Functions in Migration of Zebrafish Myocardial Precursors
A. Kawahara (2009)
Extracellular and intracellular actions of sphingosine-1-phosphate.
G. Strub (2010)
Krüppel-Like Factor-4 Transcriptionally Regulates VE-Cadherin Expression and Endothelial Barrier Function
Colleen E. Cowan (2010)
The Sphingosine 1-Phosphate Transporter, SPNS2, Functions as a Transporter of the Phosphorylated Form of the Immunomodulating Agent FTY720*
Yu 野悠 Hisano 久 (2010)
S1P1 and VEGFR-2 form a signaling complex with extracellularly regulated kinase 1/2 and protein kinase C-alpha regulating ML-1 thyroid carcinoma cell migration.
N. Bergelin (2010)
Intracellular localization of sphingosine kinase 1 alters access to substrate pools but does not affect the degradative fate of sphingosine-1-phosphate[S]
D. Siow (2010)
Sphingosine-1-phosphate Lyase Deficiency Produces a Pro-inflammatory Response While Impairing Neutrophil Trafficking*
M. L. Allende (2010)
Sphingosine 1-Phosphate Lyase Deficiency Disrupts Lipid Homeostasis in Liver*
M. Bektas (2010)
Stat3-induced S1PR1 expression is critical for persistent Stat3 activation in tumors
Heehyoung Lee (2010)
S1P1 and VEGFR-2 Form a Signaling Complex with Extracellularly Regulated Kinase 1/2 and Protein Kinase C-α Regulating ML-1 Thyroid Carcinoma Cell Migration
N. Bergelin (2010)
An update on sphingosine-1-phosphate and other sphingolipid mediators.
H. Fyrst (2010)
Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis
V. Brinkmann (2010)
Shaping of terminal megakaryocyte differentiation and proplatelet development by sphingosine-1-phosphate receptor S1P4.
S. Golfier (2010)
An overview of sphingolipid metabolism: from synthesis to breakdown.
Christopher R. Gault (2010)
Receptor tyrosine kinase-G-protein-coupled receptor signalling platforms: out of the shadow?
N. Pyne (2011)
Caveolin-1–eNOS signaling promotes p190RhoGAP-A nitration and endothelial permeability
M. Siddiqui (2011)
Endocannabinoid tone versus constitutive activity of cannabinoid receptors
A. Howlett (2011)
Sphingosine-1-Phosphate Receptor 3 Promotes Recruitment of Monocyte/Macrophages in Inflammation and Atherosclerosis
P. Keul (2011)
The outs and the ins of sphingosine-1-phosphate in immunity
S. Spiegel (2011)
Engagement of S1P₁-degradative mechanisms leads to vascular leak in mice.
M. Oo (2011)
Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M
C. Christoffersen (2011)
Dissecting the Role of the S1P/S1PR Axis in Health and Disease
J. J. Aarthi (2011)
Molecular mechanism and physiological functions of clathrin-mediated endocytosis
H. McMahon (2011)
Protection of LPS-induced murine acute lung injury by sphingosine-1-phosphate lyase suppression.
Yutong Zhao (2011)
S1P4 receptor mediates S1P-induced vasoconstriction in normotensive and hypertensive rat lungs
H. Ota (2011)
Regulation of sphingosine kinase and sphingolipid signaling.
S. Pitson (2011)
Heterotrimeric G proteins, focal adhesion kinase, and endothelial barrier function.
Tracy Thennes (2012)
Sphingosine-1-phosphate signaling and its role in disease.
M. Maceyka (2012)
New roles of HDL in inflammation and hematopoiesis.
Xuewei Zhu (2012)
Flow-regulated endothelial S1P receptor-1 signaling sustains vascular development.
B. Jung (2012)
The sphingosine-1-phosphate transporter Spns2 expressed on endothelial cells regulates lymphocyte trafficking in mice.
S. Fukuhara (2012)
Sphingosine-1-phosphate receptor-3 is a novel biomarker in acute lung injury.
Xiaoguang Sun (2012)
Mouse SPNS2 Functions as a Sphingosine-1-Phosphate Transporter in Vascular Endothelial Cells
Yu Hisano (2012)
The sphingosine-1-phosphate receptor S1PR1 restricts sprouting angiogenesis by regulating the interplay between VE-cadherin and VEGFR2.
K. Gaengel (2012)
Visualizing neuromodulation in vivo: TANGO-mapping of dopamine signaling reveals appetite control of sugar sensing.
Hidehiko K. Inagaki (2012)
Sphingosine 1-phosphate receptor 5 mediates the immune quiescence of the human brain endothelial barrier
R. van Doorn (2012)
Sphingosine 1-Phosphate Receptor Signaling Regulates Proper Embryonic Vascular Patterning*
Karen Mendelson (2012)
Sphingosine-1-Phosphate Receptor 3 Promotes Neointimal Hyperplasia in Mouse Iliac-Femoral Arteries
Takuya Shimizu (2012)
Role of FAK in S1P-regulated endothelial permeability.
P. Belvitch (2012)
The tyrosine phosphatase SHP2 regulates recovery of endothelial adherens junctions through control of β-catenin phosphorylation
Ilse Timmerman (2012)
Sphingosine-1-phosphate, FTY720, and sphingosine-1-phosphate receptors in the pathobiology of acute lung injury.
V. Natarajan (2013)
Sphingosine‐1‐phosphate receptor 2
M. Adada (2013)
Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond
Gregory T Kunkel (2013)
Conditional deletion of FAK in mice endothelium disrupts lung vascular barrier function due to destabilization of RhoA and Rac1 activities.
T. Schmidt (2013)
Sphingosine-1-phosphate and its receptors: structure, signaling, and influence.
H. Rosen (2013)
Transcriptional downregulation of S1pr1 is required for establishment of resident memory CD8+ T cells
Cara N. Skon (2013)
Moesin Controls Clathrin-Mediated S1PR1 Internalization in T Cells
Akira Nomachi (2013)
S1pr2/Gα13 signaling controls myocardial migration by regulating endoderm convergence
Ding Ye (2013)
Critical role of sphingosine-1-phosphate receptor 2 (S1PR2) in acute vascular inflammation.
Guoqi Zhang (2013)
Post-translational regulation of sphingosine kinases.
Huasheng Chan (2013)
Spns2, a transporter of phosphorylated sphingoid bases, regulates their blood and lymph levels, and the lymphatic network
M. Nagahashi (2013)
Loss of signaling via Gα13 in germinal center B cell-derived lymphoma
J. Muppidi (2014)
Coupling between endocytosis and sphingosine kinase I recruitment
Hongying Shen (2014)
β-arrestins and G protein-coupled receptor trafficking.
X. Tian (2014)
Sphingosine-1-phosphate receptor 1 reporter mice reveal receptor activation sites in vivo.
M. Kono (2014)
An update on the biology of sphingosine 1-phosphate receptors
V. Blaho (2014)
Lysophospholipid receptor nomenclature review: IUPHAR Review 8
Y. Kihara (2014)
Sphingosine 1-phosphate signalling
Karen Mendelson (2014)
Cardiovascular effects of statins, beyond lipid-lowering properties.
Christos G Mihos (2014)
Interaction of Integrin β4 With S1P Receptors in S1P‐ and HGF‐Induced Endothelial Barrier Enhancement
Xiuqin Ni (2014)
Erythrocyte-derived sphingosine 1-phosphate is essential for vascular development.
Yuquan Xiong (2014)
Endothelial Focal Adhesion Kinase Transcriptionally Regulates S1P1 to Maintain Lung Vascular Barrier Function
Pascal Yazbeck (2015)
Differential activation of receptors and signal pathways upon stimulation by different doses of sphingosine‐1‐phosphate in endothelial cells
Q. Li (2015)
Lipid phosphate phosphatases and their roles in mammalian physiology and pathology
Xiaoyun Tang (2015)
Rac1 functions as a reversible tension modulator to stabilize VE-cadherin trans-interaction
N. Daneshjou (2015)
Critical role of sphingosine-1-phosphate receptor-2 in the disruption of cerebrovascular integrity in experimental stroke
Gab Seok Kim (2015)
HDL-bound sphingosine 1-phosphate acts as a biased agonist for the endothelial cell receptor S1P1 to limit vascular inflammation
S. Galvani (2015)
S1PR1 Tyr143 phosphorylation downregulates endothelial cell surface S1PR1 expression and responsiveness
Alejandra Chavez (2015)
Binding of the sphingolipid S1P to hTERT stabilizes telomerase at the nuclear periphery by allosterically mimicking protein phosphorylation
S. Panneer Selvam (2015)
Spinster 2, a sphingosine‐1‐phosphate transporter, plays a critical role in inflammatory and autoimmune diseases
M. Donoviel (2015)
Exit Strategies: S1P Signaling and T Cell Migration.
A. Baeyens (2015)
Platelet and Erythrocyte Sources of S1P Are Redundant for Vascular Development and Homeostasis, but Both Rendered Essential After Plasma S1P Depletion in Anaphylactic Shock.
Salomé L Gazit (2016)
Diverse activation pathways in class A GPCRs converge near the G-protein-coupling region
A. Venkatakrishnan (2016)
Endocytosis of Ligand‐Activated Sphingosine 1‐Phosphate Receptor 1 Mediated by the Clathrin‐Pathway
P. Reeves (2016)
Autosomal-Recessive Hearing Impairment Due to Rare Missense Variants within S1PR2.
R. Santos-Cortez (2016)
Impaired endothelial barrier function in apolipoprotein M‐deficient mice is dependent on sphingosine‐1‐phosphate receptor 1
Pernille M. Christensen (2016)
FOXF1 maintains endothelial barrier function and prevents edema after lung injury
Yuqi Cai (2016)
Targeting sphingosine-1-phosphate signaling in lung diseases.
D. Ebenezer (2016)
Mfsd2b is essential for the sphingosine-1-phosphate export in erythrocytes and platelets
T. M. Vu (2017)
The Diverse Roles of Arrestin Scaffolds in G Protein–Coupled Receptor Signaling
Y. Peterson (2017)
Polarized actin and VE-cadherin dynamics regulate junctional remodelling and cell migration during sprouting angiogenesis
Jiahui Cao (2017)
Methods for the Development of In Silico GPCR Models.
P. Morales (2017)
Bioluminescence imaging of G protein-coupled receptor activation in living mice
M. Kono (2017)
The balance between Gαi-Cdc42/Rac and Gα12/13-RhoA pathways determines endothelial barrier regulation by sphingosine-1-phosphate
N. R. Reinhard (2017)
Protein Interactions at Endothelial Junctions and Signaling Mechanisms Regulating Endothelial Permeability.
Y. Komarova (2017)
Sphingosine 1-Phosphate Receptor 1 Signaling in Mammalian Cells
N. Pyne (2017)
Beyond Immune Cell Migration: The Emerging Role of the Sphingosine-1-phosphate Receptor S1PR4 as a Modulator of Innate Immune Cell Activation
Catherine Olesch (2017)
Simvastatin-induced sphingosine 1−phosphate receptor 1 expression is KLF2-dependent in human lung endothelial cells
Xiaoguang Sun (2017)
A new inhibitor of the β-arrestin/AP2 endocytic complex reveals interplay between GPCR internalization and signalling
Alexandre Beautrait (2017)
An engineered S1P chaperone attenuates hypertension and ischemic injury
S. Swendeman (2017)
KLF2 and KLF4 control endothelial identity and vascular integrity.
Panjamaporn Sangwung (2017)
A sphingosine‐1‐phosphate receptor type 1 agonist, ASP4058, suppresses intracranial aneurysm through promoting endothelial integrity and blocking macrophage transmigration
R. Yamamoto (2017)
Characteristics of lipid metabolism including serum apolipoprotein M levels in patients with primary nephrotic syndrome
Lagu He (2017)
Sphingolipids Signaling in Lamellipodia Formation and Enhancement of Endothelial Barrier Function.
P. Fu (2018)
Sphingosine Kinase 1 Regulates Inflammation and Contributes to Acute Lung Injury in Pneumococcal Pneumonia via the Sphingosine-1-Phosphate Receptor 2
B. Gutbier (2018)
Sphingosine-1-Phosphate Receptor-1 Agonist Sew2871 Causes Severe Cardiac Side Effects and Does Not Improve Microvascular Barrier Breakdown in Sepsis
Sven Flemming (2018)
Stimulation of S1PR5 with A-971432, a selective agonist, preserves blood–brain barrier integrity and exerts therapeutic effect in an animal model of Huntington’s disease
A. di Pardo (2018)
Expansion of Sphingosine Kinase and Sphingosine-1-Phosphate Receptor Function in Normal and Cancer Cells: From Membrane Restructuring to Mediation of Estrogen Signaling and Stem Cell Programming
O. Sukocheva (2018)
Krüppel-Like Factors in Vascular Inflammation: Mechanistic Insights and Therapeutic Potential
David R Sweet (2018)
Current Therapies Focused on High-Density Lipoproteins Associated with Cardiovascular Disease
D. Estrada-Luna (2018)
S1P1 Modulator-Induced Gαi Signaling and β-Arrestin Recruitment Are Both Necessary to Induce Rapid and Efficient Reduction of Blood Lymphocyte Count In Vivo
Magdalena Birker-Robaczewska (2018)
Targeting Sphingosine Kinases for the Treatment of Cancer: CHAPTER ELEVEN
C. S. Lewis (2018)
Sphingosine 1‐Phosphate Receptor 1 Signaling Maintains Endothelial Cell Barrier Function and Protects Against Immune Complex–Induced Vascular Injury
N. Burg (2018)
FAK maintenance of endothelial mechanotransduction controls epigenetic repression of KLF2 and S1PR1 transcription
Dynamin internalizes tyrosine phosphorylated sphingosine 1 phosphate receptor 1 and impair downstream signaling
VE-PTP stabilizes VE-cadherin junctions and the endothelial barrier via a phosphatase-independent mechanism
V. Juettner (2019)
Apolipoprotein M induces inhibition of inflammatory responses via the S1PR1 and DHCR24 pathways.
M. Wang (2019)
Pseudomonas aeruginosa stimulates nuclear sphingosine-1-phosphate generation and epigenetic regulation of lung inflammatory injury
D. Ebenezer (2019)
Targeting the S1P receptor signaling pathways as a promising approach for treatment of autoimmune and inflammatory diseases.
Bisera Stepanovska (2019)
Sphingosine 1-phosphate and inflammation.
Hideru Obinata (2019)
Sphingosine-1-Phosphate Receptor 1 Activity Promotes Tumor Growth by Amplifying VEGF-VEGFR2 Angiogenic Signaling
Vijay Avin Balaji Ragunathrao (2019)
GPCR Signaling Regulation: The Role of GRKs and Arrestins
V. Gurevich (2019)
SPHK2-Generated S1P in CD11b+ Macrophages Blocks STING to Suppress the Inflammatory Function of Alveolar Macrophages
J. Joshi (2020)
Sphingosine 1-phosphate-regulated transcriptomes in heterogenous arterial and lymphatic endothelium of the aorta
Eric Engelbrecht (2020)
This paper is referenced by
Sphingosine-1-phosphate receptor 3 signaling.
Qian Li (2021)
Increased Serum Sphingosine-1-Phosphate Accompanied with Secretion of Hepatitis B Surface Antigen
Yalu Ren (2021)